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Background: Livestock that consume locoweed exhibit multiple neurological symptoms, including dispirited
behavior, staggered gait, trembling, ataxia, impaired reproductive function and cellular vacuolar degeneration of
multiple tissues due to toxicity from plant-derived alkaloids such as swainsonine.
Results: Swainsonine was administered to F0 and F1 mice by intraperitoneal injection before, during and after
pregnancy at the following doses: 0.525 mg/kg BW(I), 0.2625 mg/kg BW(II), 0.175 mg/kg BW(III) and 0 mg/kg BW(IV).
Hemosiderin deposits were observed the lamina propria of endometrium in uterus and the red pulp of spleen.
Ovary corpus lutea counts in F0 mice were higher in swainsonine-treated mice compared to control mice. Indirect
bilirubin content and reticulocyte numbers were increased in swainsonine-treated F0 and F1 generation mice
compared to control group (P < 0.05). Lactate dehydrogenase, alkaline phosphatase, aspartate aminotransferase
and alanine aminotransferase content in F0-I and F0-II mice were significantly increased compared with F0-IV
group mice (P < 0.05). Red blood cells, hemoglobin and mean corpuscular hemoglobin levels were significantly
decreased in F0 and F1 mice compared with the control group (P < 0.05).
Conclusions: Swainsonine exerts effects on estrus period and reproductive ability, and offspring of dams
dosed with swainsonine were affected in-utero or from nursing. Damage to liver, uterus and spleen, as well
as hematological changes, are observable before neurological symptoms present.
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Locoweeds are perennial herbaceous plants of the
Astragalus spp and Oxytropis spp. containing the toxic
indolizidine alkaloid swainsonine [1]. Locoism causes
significant economic losses to the livestock industry on
western grasslands in China and the United States [2].
Swainsonine, a trihydroxy indolizidine alkaloid, is the
primary toxin in locoweeds [1]. Astragalus and Oxytropis
species that contain swainsonine are found on multiple
continents, and have poisoned animals in South America
and Asia [3,4]. Early studies demonstrated that natural
or experimental long-term ingestion of swainsonine-
containing plants causes serious disorders in reproductive
functions of livestock (cattle, sheep, horses and goat), in-
cluding failure to conceive and early embryo loss or abor-
tion, resulting in great economic losses to the livestock
industry [5-8]. Therefore, various animal models have* Correspondence: zhaobaoyu12005@163.com
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reproduction and development, including goat, sheep and
cattle. Locoweed poisoning is usually chronic, and the
toxic symptoms are observed after a few weeks of loco-
weed feeding. Mice were fed a small quantity of locoweed
for four months, demonstrated that pathological and clin-
ical damage to internal organs and neuronal processes
were reversible [9]. In this study, we then selected four
groups of mice to treat with either vehicle control or
swainsonine (10 each group, F0-I: 0.525 mg/kg BW; F0-II:
0.2625 mg/kg BW; F0-III: 0.175 mg/kg BW and F0-IV:
0 mg/kg BW). After treatment with swainsonine for two
weeks, female mice were mated to untreated male mice,
and pups were kept with dams for one month. We sacri-
ficed dams and offspring and observed swainsonine toxicity
effects on internal organs via histopathological analysis as
well as altered hematological and blood biochemical pa-
rameters in both parent and offspring mice.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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TLC detection
All extracts were collected using column chromatography,
which was placed on the thin layer plate using the capil-
lary sample. Figure 1 show a developed TLC plate. This
purple colored spots are swainsonine, the rose red colored
spots are the swainsonine analogs as determined by com-
parison with the swainsonine standard.
Histological effects of swainsonine treatment in F0 and F1
mice
Examination of heart, lung and kidney of treated F0 and
F1 mice revealed no marked changes (data not shown).
Histological changes in liver from swainsonine administra-
tion are shown in Figure 2 (a-d). Livers of F0 swainsonine-
treated mice displayed few differences compared with their
controls, with cellular infiltrates consisting mostly of in-
flammatory cells, neutrophils and granulocytes in F0-I, F0-
II and F0-III mice. No histopathological differences were
noted between F1-I, F1-II, F1-III and F1-IV control mice
(Figure 2 (e-h)).
Histological analysis indicated important alterations in
the spleen and uterus. As evident in Figure 3 (a-h), dose-
related expansion of splenic red pulp was characterized by
large numbers of inflammatory cells and lymphocytes,
hypertrophy of splenic cells and a considerable number
of macrophages and megakaryocytes. Increased extrame-
dullary hemosiderin deposition were also observed in
the red pulp of spleen in F0 and F1 mice (Figure 3 (a-c)).Figure 1 Thin-layer chromatography of swainsonine. The
standard swainsonine sample (left arrow). The swainsonine is
represented by the deep purple spots (right arrow).Hemosiderin deposition in the spleen of F1 mice was not
observed (Figure 3 (e-h)).
Histological alterations in uterus of mice exposed to
swainsonine were more noticeable, and this effect was inde-
pendent of dose (Figure 4). Hemosiderin deposits were
observed in the lamina propria of endometrium in uterus
of F0 generation mice treated with swainsonine compared
with their controls (Figure 4 (a-d)). Focal collection of large
numbers of neutrophils were seen in uterus mucosa of F0
generation mice (Figure 4 (a-c)). However, no noticeable al-
terations in uterus of F1 mice were observed (Figure 4 (e-h)).
Histopathological analysis of ovaries in swainsonine-
treated mice revealed dose-dependent changes compared
with controls (Figure 5 (a-d)). F0-I and F0-II mice dis-
played decreased numbers of primordial and primary
follicles compared to F0-IV controls. F0-I and F0-II mice
exhibited increased numbers and size of corpus lutea
compared with F0-IV control mice (Figure 5 (a-d)). How-
ever, no histopathological changes in the ovary of F1 mice
were observed (Figure 5 (e-h)).
Biochemical marker characterization of
swainsonine-treated mice
Indirect bilirubin (IBIL) content of F0-I, F0-II and F0-III
mice was significantly increased when compared with F0-IV
controls (P < 0.05). Lactate dehydrogenase (LDH), alkaline
phosphatase (ALP), aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) content of F0-I and F0-II
mice were significantly increased compared with F0-IV con-
trols (P < 0.05). Furthermore, indirect bilirubin (IBIL) level
of F1-I, F1-II and F1-III mice were significantly increased
compared with F1-IV controls (P < 0.05). Examination of
lactate dehydrogenase (LDH), alkaline phosphatase (ALP),
aspartate aminotransferase (AST) and alanine aminotrans-
ferase (ALT) content in swainsonine-treated F1 mice com-
pared with controls revealed no statistically significant
differences (Table 1).
Hematological characterization of swainsonine-treated
mice
Examination of F0 dams revealed that WBCs in F0-I,
F0-II and F0-III treatment groups were not significantly
different from F0-IV controls (P > 0.05). RBCs, and levels
of Hb, HCT, PLT, and MCH in F0-I, F0-II and F0-III treat-
ment groups were significantly decreased compared with
F0-IV controls (P < 0.05). MCV and reticulocyte levels in
F0-I, F0-II and F0-III treatment groups were significantly
increased compared with F0-IV controls (P < 0.05). Exam-
ination of F1 mice revealed that reticulocytes in F1-I, F1-II
and F1-III treatment groups were significantly increased
compared with F1-IV controls (p < 0.05). WBCs counts in
F1-I, F1-II and F1-III treatment groups were not signifi-
cantly different from F1-IV controls (P > 0.05). RBCs, Hb
and MCH levels in F1-I, F1-II and F1-III treatment groups
Figure 2 Histological changes in F0 and F1 mice after swainsonine treatment. a-d represent changes in the liver of F0-I, F0-II, F0-III and F0-IV
(×400); e-h represent changes in the liver of F1-I, F1-II, F1-III and F1-IV (×400).
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(P < 0.05). HCT levels in F1-I group mice were signifi-
cantly decreased compared with F1-IV control mice
(P < 0.05), and MCV levels in F1-I and F1-II mice were
significantly increased compared with F1-IV control mice
(P < 0.05) (Table 2).Figure 3 Histological changes in F0 and F1 mice after swainsonine tre
F0-IV (×400); e-h represent changes in the spleen of F1-I, F1-II, F1-III and F1-IDiscussion
Swainsonine, a trihydroxy indolizidine alkaloid, is the
main toxin in locoweed. The structure of the swainso-
nine cation is similar to the structure of mannose, and
it has a higher affinity than mannose for mannosidase
[10]. Swainsonine is a well-known inhibitor of lysosomalatment. a-d represent changes in the spleen of F0-I, F0-II, F0-III and
V (×400).
Figure 4 Histological changes in F0 and F1 mice after swainsonine treatment. a-d represent changes in the uterus of F0-I, F0-II, F0-III and
F0-IV (×400); e-h represent changes in the uterus of F1-I, F1-II, F1-III and F1-IV (×400).
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induces toxicity through inhibition of ɑ-mannosidase
and subsequent glycoprotein synthesis. This enzymatic
dysfunction causes accumulation of complex oligosac-
charides in lysosomes as well as the production of a mix-
ture of mannose and asparagine polysaccharides, resultingFigure 5 Histological changes in F0 and F1 mice after swainsonine tre
(×100); e-h represent changes in the ovary of F1-I, F1-II, F1-III and F1-IV (×40in vacuolar degeneration in multiple cells [11]. Clin-
ical symptoms in livestock are characterized by neuro-
logical and behavioral disorders, gait abnormalities,
difficulty standing, abnormal posture, emaciation, re-
productive disorders and cellular vacuolar degener-
ation of multiple tissues by pathological observationatment. a-d represent changes in the ovary of F0-I, F0-II, F0-III and F0-IV
0).
Table 1 Serum marker assessment in swainsonine-treated mice
LDHU/L ALPU/L ASTU/L ALTU/L IBILmg/dL
F0-I 783.9 ± 96.2* 269.84 ± 31.58* 184.32 ± 12.5* 65.87 ± 8.57* 0.43 ± 0.03*
F0-II 718.5 ± 95.7* 221.47 ± 32.85* 178.7 ± 10.8* 59.78 ± 9.55* 0.37 ± 0.05*
F0-III 623.8 ± 99.3 193.58 ± 35.87 120.87 ± 11.8 48.47 ± 8.77 0.029 ± 0.02*
F0-IV 587.2 ± 95.8 188.97 ± 27.31 98.11 ± 9.36 41.05 ± 9.58 0.11 ± 0.011
F1-I 547.54 ± 93.25 214.85 ± 7.5 116.58 ± 9.32 47.32 ± 8.50 0.28 ± 0.03*
F1-II 551.87 ± 90.58 218.55 ± 8.1 111.56 ± 9.65 45.36 ± 8.01 0.20 ± 0.01*
F1-III 569.65 ± 85.79 203.51 ± 7.5 105.8 ± 12.21 42.11 ± 7.59 0.18 ± 0.02*
F1-IV 554.88 ± 80.69 198.65 ± 6.8 92.34 ± 8.65 38.25 ± 7.20 0.095 ± 0.02
The values are the mean ± S.D.
*Significantly different from the control group at same generation (P < 0.05).
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and show organ selective vacuolar degeneration by mice
given swainsonine via pathological observation. We found
hemosiderin deposition in spleen and enlargement of
spleen in F0 and F1 mice, and a large amount of hemosid-
erin deposition in uterus in F0 mice. When animals are
fed a dose of swainsonine arrive to a certain time, the
vacuolar degeneration of pathological change will show in
the internal organs [9]. Therefore, we think that this
experiment period did not arrive to a certain time that
vacuolar degeneration found in organ. However, in our
previous experiment, we also found hemosiderin depos-
ition in spleen of rat and goat using a different dose of
swainsonine [14]. We posited that some tissue bleeding
occurred after swainsonine administration and found that
hemosiderin deposition leads to damage in some tissues.
Whether the presence of hemosiderin deposition can be
used as a pathological marker of swainsonine poisoning
requires further research.
The experiment results showed that two ways were not
significantly different between irrigation and intraperito-
neal injection by Liu Tianya [15]. Therefore, we selected
the way of intraperitoneal injection for give mice to swain-
sonine. In this study, we demonstrate that swainsonine ex-
erts hepatotoxicity in F0 mice. Alterations in liver weight
and histopathological changes in liver of swainsonine-Table 2 Hematological assessment in swainsonine-treated mi
WBC × 109/L RBC × 1012/L Hb g/L HCT %
F0-I 7.98 ± 1.12 6.01 ± 1.54* 100.58 ± 21.58* 0.36 ± 0.03*
F0-II 7.21 ± 1.08 6.37 ± 1.23* 108.58 ± 25.46* 0.40 ± 0.03*
F0-III 7.19 ± 1.10 6.58 ± 1.15* 112.87 ± 26.54* 0.41 ± 0.02*
F0-IV 7.85 ± 1.75 8.45 ± 1.12 153.77 ± 20.58 0.53 ± 0.05
F1-I 7.89 ± 0.95 6.58 ± 1.12* 121.69 ± 25.41* 0.51 ± 0.025*
F1-II 7.01 ± 0.65 7.05 ± 1.25* 125.6 ± 23.15* 0.59 ± 0.035
F1-III 7.95 ± 0.85 7.55 ± 1.30* 139.85 ± 32.15* 0.60 ± 0.04
F1-IV 7.75 ± 1.23 8.36 ± 1.05 149.85 ± 23.56 0.62 ± 0.04
The values are the mean ± S.D.
*Significantly different from the control group at same generation (P < 0.05).treated mice were slight. Liver from swainsonine-treated
mice showed cellular infiltrates consisting mostly of in-
flammatory cells and neutrophil granulocytes. Significant
increase of liver weight and significant alterations in levels
of AST, ALT and ALP in plasma may indicate hepatic in-
jury in F0 mice given swainsonine. The elevations of ALT,
AST and ALP observed in swainsonine-treated mice may,
in part, be due to the hepatic hypertrophic effect of swain-
sonine and/or may also represent borderline chronic liver
toxicity [16,17]. Increased LDH activity levels have been
observed in conditions of chemical stress when high levels
of energy are required in a short period of time [18]. In
the present study, LDH was significantly increased in F0
mice. However, no significant differences in biochemical
markers were found between treatment and control mice
F1 mice. This is consistent with the lack of histopatho-
logical changes in liver of F1 mice.
The present study identifies important histological al-
terations in the spleen in F0 and F1 mice, namely expan-
sion of red pulp with vascular congestion. Furthermore,
the endometrium of the uterus displayed notable depos-
ition of hemosiderin granules in a swainsonine-treated
dose-dependent manner in F0 mice. The molecular
weight of swainsonine is small enough to penetrate the
placental barrier and expose offspring in-utero. A major
function of the spleen is to remove aged and damagedce
MCV fL PLT × 109/L MCH fl Reticulocytes %
78.32 ± 6.58* 519.74 ± 53.9* 39.95 ± 7.58* 5.54 ± 0.78*
76.32 ± 6.68* 523.8 ± 48.5* 40.01 ± 6.52* 4.85 ± 0.85*
72.58 ± 6.98* 548.9 ± 51.25* 42.11 ± 7.56* 4.56 ± 0.96*
54.25 ± 5.44 624.88 ± 58.5 52.10 ± 7.01 2.13 ± 0.58
69.58 ± 6.32* 588.39 ± 56.21* 40.88 ± 7.85* 4.38 ± 0.29*
65.32 ± 7.32* 605.81 ± 63.5* 42.02 ± 7.96* 4.18 ± 0.74*
60.25 ± 5.91 632.87 ± 65.21 44.32 ± 8.81* 3.66 ± 0.95*
58.65 ± 5.64 658.2 ± 63.9 53.53 ± 8.21 2.07 ± 0.66
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deposition in spleen can result in the destruction of
macrophages and the release of the contents such as
iron, toxic compounds and/or its metabolites into spleen
[20]. Toxic effects in both F1 and F0 mice include reduc-
tion of RBCs, reduction in levels of Hb, HCT, PLT and
MCH, as well as an increase in the number of reticulo-
cytes, suggesting the development of anemia [21]. Sig-
nificant increases in IBIL were observed in F0 and F1
mice given swainsonine. The increase of IBIL further in-
dicates that swainsonine could be damaging red blood
cells. When organs bleed, red blood cells are phagocy-
tized by macrophages and degraded by lysosomes; Fe3+
of hemoglobin from lysed red blood cells can combine
with protein to form hemosiderin. Because we observed
decreased RBCs, and decreased levels of Hb, MCH and
MCV as well as an increase in reticulocytes, we suspect
that our dose levels of swainsonine may lead to anemia.
Swainsonine is water-soluble and rapidly distributed to
many parts of the body. In previous studies, swainsonine
concentrations varied widely in various tissues and or-
gans of sheep that had ingested locoweed [22-24]. In this
study, uterus of swainsonine-treated F0 mice was heavily
damaged. This was characterized by the presence of he-
mosiderin deposits in the lamina propria of endomet-
rium in uterus of F0 mice in this study. In ovary, F0-I
and F0-II mice displayed decreased numbers of primor-
dial and primary follicles compared to F0-IV controls. In
addition, F0-I and F0-II mice displayed increased size and
number of corpus lutea compared to F0-III and F0-IV.
The lesions in ovary and uterus were dose-dependently
observed in F0-I, F0-II and F0-III treatment groups. How-
ever, F1 did not display notable histopathological changes
in the uterus and ovary. Swainsonine easily accumulates
in uterus at high concentrations, which may impair uterus
and ovary function and cause toxicity. In the present
study, the uterus suffered noticeable damage, which led to
a decline in the rate of conception, an increase in the rate
of abortion and increases in stillborn births. It is suspected
that significant early embryonic loss occurs in cattle and
sheep grazing locoweed, and there are documented effects
of swainsonine on oocyte maturation, fertilization and
subsequent embryonic implantation and development
[24]. Increased numbers of corpus lutea in ovary can lead
to delayed or halted estrus. The pathological lesions we
observed, combined with altered hematological and serum
biochemical parameters in swainsonine-treated mice, sug-
gest that exposure to swainsonine may lead to inhibition
of reproductive performance under certain doses.
Conclusions
Based on sub-chronic toxicity results, our data estab-
lishes effects of swainsonine on reproductive toxicity in
a mouse model. In addition, we found that swainsoninecan cause hematological changes and lesions in spleen,
uterus, ovary and liver. Furthermore, we provide evi-
dence of trans-generational swainsonine toxicity through
placental barrier and milk. Spleen, heart, liver, lung, kid-
ney, uterus and ovary were among the organs affected in
offspring of dams given swainsonine. Large amounts of
hemosiderin deposition in uterus and spleen were ob-
served in the parent generation. We present evidence that
hemosiderin deposition may preclude vacuolar degener-
ation in some tissues of mice given swainsonine. Alter-
ations in hematological and histopathological parameters
suggest a link to anemia and decreases in reproduction
ability. Our data suggest that anemia and organ-specific
hemosiderin deposition followed by destruction of red
blood cells are clinical features of swainsonine-treated
mice. However, further research is needed to elucidate
specific mechanisms of swainsonine toxicity.
Methods
Ethical statement
Female Rattus norvegicus mice were supplied by the
Animal Center of the Fourth Military Medical Univer-
sity. During the experiment, mice were housed individu-
ally in polypropylene cages with laboratory grade pine
shavings as bedding. Mice were maintained in a con-
trolled environment with temperature maintained be-
tween 19-25°C, relative humidity maintained between
40-70%, >8 air changes/hour, and with a 12:12-h light: dark
cycle. The experimental procedures were in accordance
with the Ethical Principles (Animal [Scientific Procedures]
Act 2012) in Animal Research adopted by the China
College of Animal Experimentation and were approved
by the College of Veterinary Medicine- Northwest A&F
University.
Study design
Extraction of swainsonine from locoweed
The aerial portion of Oxytropis kansuensis was collected
from the grassland in Tianzhu city, Gansu province in
July 2011. The plants were then taxonomically identified by
Zhao Bao-Yu, College of Veterinary Medicine, Northwest
A and F University, China. The plants were subsequently
dried in the shade, finely ground and comminuted.
The extraction and analysis method of swainsonine
from Oxytropis kansuensis was conducted as previously
described [25].
Analysis of swainsonine
Thin-layer chromatography (TLC) detection was per-
formed on silica gel G precoated plates with the developing
solvents chloroform:methanol:ammonia:water (70:26:2:2,
V/V), chloroform:methanol:ammonia:water (70:26:10:10,
V/V), and methanol: ethylacetate: ammonia (4:1:1,V/V)
and modified potassium heptaiodobismuthate reagent or
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the chromogenic agent.
The extracts were dissolved in methanol, spotted onto
the GF254 silica gel G precoated plates. The plates were
developed with an ascendant run after saturation with
the mobile phase in a s glass chamber for 5–10 min. The
plates were dried when the mobile phase was 10 mm from
the front edge of the plates. The plates were stained suc-
cessively with a spray of H2O2 (heated for 10 min in an
oven at 115°C), a spray of 10% acetic anhydride in dehy-
drated alcohol (heated at the same temperature until the
smell of acetic anhydride disappeared) and finally a spray
of Ehrilich’s reagent (heated for 15 min at 120°C). The
color of the spots in each plate was recorded, and the Rf
was determined [25].
Animals to experimental groups
Female mice (N = 40, six weeks old) were divided into four
equal groups of 10 mice (10 each group, F0-I: 0.525 mg/kg
BW; F0-II: 0.2625 mg/kg BW; F0-III: 0.175 mg/kg BW and
F0-IV: 0 mg/kg BW). All mice were administered swainso-
nine by intraperitoneal injection 14 days before the mating
period followed by re-administration every three days.
After this pre-mating period, the treated mice were trans-
ferred to the home cage of a male in the same group and
cohabited on a 1:1 basis until achievement of successful
mating. During the mating period, mice were examined
daily for presence of vaginal plugs, and a vaginal plug was
considered evidence of successful mating. Pregnant dams
continued to receive swainsonine every three days via
intraperitoneal injection throughout parturition and the
lactation. Upon weaning of four-week-old pups (F1), the
dams (F0) were sacrificed, and the liver, kidney, heart,
spleen, lung, uterus and ovary were collected. In total, F0
mice were given swainsonine for six to eight weeks in the
whole experiment.
Female offspring (F1) of treated dams were selected
from each of the four treatment groups (40 F1 mice in
total, 10 from each F0 treatment group). The F1 offspring
were not treated with swainsonine, however, the dams
continued to be dosed while nursing their F1 pups. The F1
offspring were then sacrificed after approximately 1 month
of nursing. The liver, kidney, heart, spleen, lung, uterus,
and ovary were collected.
All F0 group mice received intraperitoneal injections
of swainsonine once every three days under aseptic con-
ditions. Upon sacrifice, the liver, kidney, heart, spleen,
lung, uterus and ovary were trimmed of extraneous fat
and weighed immediately.
Histopathological preparation
All tissues were removed and fixed in 10% formaldehyde
at room temperature. The tissue samples were then dehy-
drated and embedded in paraffin according to standardhistological procedures. Serial cross-sections of 3 μm were
prepared from each organ. The sections were mounted
and stained with hematoxylin-eosin.
Hematological assessment
White blood cells (WBCs), red blood corpuscles (RBCs),
hemoglobin (Hb), hematocrit (HCT), mean corpuscular
volume (MCV), blood platelets (PLTs), mean corpuscular
hemoglobin (MCH) and reticulocyte counts were deter-
mined by automatic hematological analyzer, MEK-8222 K
(TOA Medical Electronics, Kobe, Japan).
Blood biochemical analysis
Blood was collected when mice were sacrificed. Lactate
dehydrogenase (LDH), aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase
(ALP) and indirect bilirubin (IBIL) were quantitated using
the Beckman Synchron CX7 Delta Chemistry Analyzer
(Beckman, USA).
Statistical methods
The statistical software “Statistical Product and Service
Solutions” (SPSS V11.3) was used to determine statisti-
cally significant differences between treatment groups and
the control group. A one-way ANOVA was used to evalu-
ate the homogeneity of the data, and a least squared dif-
ferences model or Dunnett’s multiple comparison test
were then used. Values of p < 0.05 were considered signifi-
cant. The data are presented as the group mean values ±
SD (standard deviation).
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